Investigation of in-vitro Anti-inflammatory and Lipid- modulating Activities of <I>Catharanthus roseus</I> Flower Extract in Experimental Model of Hyperlipidaemia

Catharanthus roseus (Periwinkle), a perennial medicinal plant of the Apocynaceae family, contains a variety of bioactive compounds distributed throughout the plant. Traditionally, it has been used by communities in the East Godavari region for treating menstrual disorders, wound healing, bacterial infections, ulcers, and diarrhoea. However, scientific evidence supporting its anti-inflammatory and lipid-lowering properties, particularly from its flowers, remains limited. The present study aimed to evaluate the anti-inflammatory and hypolipidemic effects of C. roseus flower extract using both in vitro and in vivo models. In vitro anti-inflammatory activity was assessed by protein denaturation and HRBC membrane stabilization methods. For in vivo studies, hyperlipidaemia was induced in rats using a high-fat diet supplemented with cholesterol for 3–4 weeks. Body weight was monitored weekly, and blood samples were analysed for lipid profile parameters including Total Cholesterol (TC), Triglycerides (TG), Low-Density Lipoprotein Cholesterol (LDL-C), and High-Density Lipoprotein Cholesterol (HDL-C). Treatment groups received graded doses of the flower extract and were compared with hyperlipidaemic controls. The extract showed significant reductions in TC (25–35%), TG (28–40%), and LDL-C (30–45%), along with an increase in HDL-C (12–20%). In vitro studies demonstrated dose-dependent inhibition of protein denaturation (40–70%) and HRBC membrane stabilization (45–72%), indicating strong anti-inflammatory activity. Major Findings: The findings suggest that C. roseus flower extract possesses significant anti-inflammatory and hypolipidemic effects, supporting its potential therapeutic application in managing inflammation and hyperlipidaemia.

View article page

Download PDF